Unlocking Externally Sponsored Research Value
November 21 @ 10:00 AM – 11:00 AM EST
As Biopharma and regulators’ appetite for understanding the value of medicines in the real world increases—alongside the desire to be closer to patients and providers—a new lens is being placed on Externally Sponsored Research (ESR) as a key pillar in Evidence Generation (EvGen). The ability to execute EvGen strategies through Company Sponsored Studies (CSS) alone is being stretched, resulting in many companies looking to more strategic use of ESR, including with registrational intent and for signal seeking (e.g., biomarker exploration).
Learning Objectives
- Articulate the key trends affecting ESR today.
- Understand how industry leaders are using ESR to support evidence generation.
- Identify best-practice techniques for delivery of ESR trials.
Speakers:
Moderator:
Kelli Rock-Walker
Managing Director, Medical Affairs
Syneos Health
Speaker:
Kelly Haines
Senior Director, Head, Medical Study Operations
Regeneron
